The phenotype of alveolar-associated fibroblasts (Afb) in sarcoidosis (SA)
and idiopathic pulmonary fibrosis (IPF) is unclear. In the present study, w
e characterized the cytoskeletal proteins and the contraction properties in
alveolar-associated fibroblasts recovered by bronchoalveolar lavage (BAL)
in the two diseases. Afb were studied from BAL cells in eight IPF and seven
SA patients. Cytoskeletal proteins were identified by ELISA and immunofluo
rescent methods. Biochemical measurements were done by dry chemistry. Contr
action was performed by a gel contraction assay. Afb alpha -SM actin measur
ed by ELISA was higher in IPF than in SA (p = 0.042). Vimentin, desmin, myo
sin, and fibroblast markers were expressed equally. Only in IPF did the Afb
reveal the myofibroblast phenotype showing a-SM actin immunofluorescence l
abeling and, by electron microscopy, filaments with associated dense bodies
with rough endoplasmic reticulum. Gel contraction showed that cells in IPF
contracted significantly more than in SA (p = 0.046 IPF versus SA). The ad
dition of ET-1 increased contraction in all groups. Dry chemistry analysis
showed higher levels (p = 0.0065) of creatine phosphokinase (CPK), lower le
vels of glucose (p = 0.0082), and similar levels of Ca2+ and lactate in the
IPF and SA Afb. Dinitrofluorobenzene (DNFB), a potent inhibitor of CPK, co
mpletely abolished spontaneous cell contraction. Afb differentiates into my
ofibroblasts with different biochemical and energetic properties in IPF. Mo
reover, Afb from IPF patients showed increased contractile properties. This
may explain the difference in the behavior patterns and outcomes of the tw
o diseases.